Quantifying mutated and unmutated BCR-ABL transcripts confirms suitability of direct sequencing sensitivity in mutation analysis of patients with chronic myeloid leukemia with secondary resistance to tyrosine kinase inhibitors, regardless of ratio values
Publication date:
2010
Publisher version:
Citación:
Leukemia and Lymphoma, 51(2), p. 350-354 (2010); doi:10.3109/10428190903470349
Descripción física:
p. 350-354
ISSN:
Collections
- Artículos [36354]